Synthetic Nanoparticles for Vaccines and Immunotherapy

Chemical Reviews

Volumn 115, Issue 19, 2015, Pages 11109-11146

  Irvine, Darrell J ^a,b,c,d   Hanson, Melissa C ^a,b   Rakhra, Kavya ^b   Tokatlian, Talar ^b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; NANOCAPSULES; NANOPARTICLES;

ANTIGEN PRESENTATION; EPITHELIAL BARRIER; EPITHELIAL CELLS; IMMUNE RESPONSE; LIPID NANOCAPSULES; MUCOSAL SURFACE; NANOPARTICLE TECHNOLOGIES; SYNTHETIC NANOPARTICLES;

VACCINES;

NANOPARTICLE; RECOMBINANT VACCINE;

ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY;

ANIMALS; HUMANS; IMMUNOTHERAPY; NANOPARTICLES; VACCINES, SYNTHETIC;

EID: 84942685991     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/acs.chemrev.5b00109     Document Type: Review

References (356)

1. Smith, D. M.; Simon, J. K.; Baker, J. R., Jr. Applications of Nanotechnology for Immunology Nat. Rev. Immunol 2013, 13, 592-605
2. Mellman, I.; Coukos, G.; Dranoff, G. Cancer Immunotherapy Comes of Age Nature 2011, 480, 480-489
3. Sheridan, B. S.; Lefrançois, L. Regional and Mucosal Memory T Cells Nat. Immunol. 2011, 12, 485-491
4. Janeway, C. A., Jr.; Travers, P.; Walport, M.; Shlomchik, M. J. Principles of Innate and Adaptive Immunity; Garland Science, New York, NY, 2001.
5. Cha, E.; Klinger, M.; Hou, Y.; Cummings, C.; Ribas, A.; Faham, M.; Fong, L. Improved Survival with T Cell Clonotype Stability after Anti-CTLA-4 Treatment in Cancer Patients Sci. Transl. Med. 2014, 6, 238ra70
6. Steinman, R. M.; Banchereau, J. Taking Dendritic Cells into Medicine Nature 2007, 449, 419-426
7. Mellman, I.; Steinman, R. M. Dendritic Cells: Specialized and Regulated Antigen Processing Machines Cell 2001, 106, 255-258
8. Kawai, T.; Akira, S. Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity Immunity 2011, 34, 637-650
9. Amanna, I. J.; Slifka, M. K. Contributions of Humoral and Cellular Immunity to Vaccine-Induced Protection in Humans Virology 2011, 411, 206-215
10. Anderson, R. P.; Jabri, B. Vaccine against Autoimmune Disease: Antigen-Specific Immunotherapy Curr. Opin Immunol. 2013, 25, 410-417
11. Snyder, A.; Makarov, V.; Merghoub, T.; Yuan, J.; Zaretsky, J. M.; Desrichard, A.; Walsh, L. A.; Postow, M. A.; Wong, P.; Ho, T. S. et al. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma N. Engl. J. Med. 2014, 371, 2189-2199
12. Centers for Disease Control and Prevention. In Epidemiology and Prevention of Vaccine-Preventable Diseases, 13 th ed.; Hamborsky, J.; Kroger, A.; Wolfe, C., Eds.; Public Health Foundation: Washington, D.C., 2015.
13. Centers for Disease Control and Prevention: Vaccines and Immunizations Publications. Parents guide to childhood immunization http://www.cdc.gov/vaccines/pubs/parents-guide/downloads/parents-guide-part3.pdf#page=10 (accessed Feb 1, 2015).
14. Wu, T. Y.; Singh, M.; Miller, A. T.; Gregorio, E.; De Doro, F.; Oro, U. D.; Skibinski, D. A. G.; Mbow, M. L.; Bufali, S.; Herman, A. E.; et al., Rational Design of Small Molecules as Vaccine Adjuvants. Sci. Transl. Med. 2014, 6.
15. Rappuoli, R.; Aderem, A. A 2020 Vision for Vaccines against HIV, Tuberculosis and Malaria Nature 2011, 473, 463-469
16. Burchill, M. A.; Tamburini, B. A.; Pennock, N. D.; White, J. T.; Kurche, J. S.; Kedl, R. M. T Cell Vaccinology: Exploring the Known Unknowns Vaccine 2013, 31, 297-305
17. Walter, S.; Weinschenk, T.; Stenzl, A.; Zdrojowy, R.; Pluzanska, A.; Szczylik, C.; Staehler, M.; Brugger, W.; Dietrich, P.-Y.; Mendrzyk, R. et al. Multipeptide Immune Response to Cancer Vaccine IMA901 after Single-Dose Cyclophosphamide Associates with Longer Patient Survival Nat. Med. 2012, 18, 1254-1261
18. Klebanoff, C. A.; Acquavella, N.; Yu, Z.; Restifo, N. P. Therapeutic Cancer Vaccines: Are We There Yet? Immunol. Rev. 2011, 239, 27-44
19. Couzin-Frankel, J. Breakthrough of the Year 2013. Cancer Immunotherapy Science 2013, 342, 1432-1433
20. Restifo, N. P.; Dudley, M. E.; Rosenberg, S. A. Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response Nat. Rev. Immunol. 2012, 12, 269-281
21. Hodi, F. S.; ODay, S. J.; McDermott, D. F.; Weber, R. W.; Sosman, J. A.; Haanen, J. B.; Gonzalez, R.; Robert, C.; Schadendorf, D.; Hassel, J. C. et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma N. Engl. J. Med. 2011, 363, 711-723
22. Topalian, S. L.; Hodi, F. S.; Brahmer, J. R.; Gettinger, S. N.; Smith, D. C.; McDermott, D. F.; Powderly, J. D.; Carvajal, R. D.; Sosman, J. A.; Atkins, M. B. et al. Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer N. Engl. J. Med. 2012, 366, 2443-2454
23. Grupp, S. A.; Kalos, M.; Barrett, D.; Aplenc, R.; Porter, D. L.; Rheingold, S. R.; Teachey, D. T.; Chew, A.; Hauck, B.; Wright, J. F. et al. Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia N. Engl. J. Med. 2013, 368, 1509-1518
24. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
25. Irvine, D. J.; Swartz, M. A.; Szeto, G. L. Engineering Synthetic Vaccines Using Cues from Natural Immunity Nat. Mater. 2013, 12, 978-990
26. Kwong, B.; Gai, S. A.; Elkhader, J.; Wittrup, K. D.; Irvine, D. J. Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity Cancer Res. 2013, 73, 1547-1558
27. Kwong, B.; Liu, H.; Irvine, D. J. Induction of Potent Anti-Tumor Responses While Eliminating Systemic Side Effects via Liposome-Anchored Combinatorial Immunotherapy Biomaterials 2011, 32, 5134-5147
28. Liu, H.; Moynihan, K. D.; Zheng, Y.; Szeto, G. L.; Li, A. V.; Huang, B.; Van Egeren, D. S.; Park, C.; Irvine, D. J. Structure-Based Programming of Lymph-Node Targeting in Molecular Vaccines Nature 2014, 507, 519-522
29. Niu, L.; Strahotin, S.; Hewes, B.; Zhang, B.; Zhang, Y.; Archer, D.; Spencer, T.; Dillehay, D.; Kwon, B.; Chen, L. et al. Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice J. Immunol. 2007, 178, 4194-4213
30. Leonard, J. P.; Sherman, M. L.; Fisher, G. L.; Buchanan, L. J.; Larsen, G.; Atkins, M. B.; Sosman, J. A.; Dutcher, J. P.; Vogelzang, N. J.; Ryan, J. L. Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12-Associated Toxicity and Interferon-Gamma Production Blood 1997, 90, 2541-2548
31. Di Giacomo, A. M.; Biagioli, M.; Maio, M. The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies across Clinical Indications Semin. Oncol. 2010, 37, 499-507
32. Salata, O. Applications of Nanoparticles in Biology and Medicine J. Nanobiotechnol. 2004, 2, 3
33. Shi, C.; Pamer, E. G. Monocyte Recruitment during Infection and Inflammation Nat. Rev. Immunol. 2011, 11, 762-774
34. Murray, P. J.; Wynn, T. A. Protective and Pathogenic Functions of Macrophage Subsets Nat. Rev. Immunol. 2011, 11, 723-737
35. Martinez, F. O.; Gordon, S. The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment F1000Prime Rep. 2014, 6, 13
36. Pinheiro, M.; Lucio, M.; Lima, J. L. F. C.; Reis, S. Liposomes As Drug Delivery Systems for the Treatment of TB: Passive & Active Targeting of Liposomes as Drug Delivery Systems for the Treatment of TB Nanomedicine 2011, 6, 1413-1428
37. Dou, H.; Destache, C. J.; Morehead, J. R.; Mosley, R. L.; Boska, M. D.; Kingsley, J.; Gorantla, S.; Poluektova, L.; Nelson, J. a.; Chaubal, M. et al. Development of a Macrophage-Based Nanoparticle Platform for Antiretroviral Drug Delivery Blood 2006, 108, 2827-2835
38. Dou, H.; Grotepas, C. B.; McMillan, J. M.; Destache, C. J.; Chaubal, M.; Werling, J.; Kipp, J.; Rabinow, B.; Gendelman, H. E. Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of neuroAIDS J. Immunol. 2009, 183, 661-669
39. Van t Klooster, G.; Hoeben, E.; Borghys, H.; Looszova, A.; Bouche, M.-P.; van Velsen, F.; Baert, L. Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation Antimicrob. Agents Chemother. 2010, 54, 2042-2050
40. Brown, J. M.; Wilson, W. R. Exploiting Tumour Hypoxia in Cancer Treatment Nat. Rev. Cancer 2004, 4, 437-447
41. Choi, J.; Kim, H. Y.; Ju, E. J.; Jung, J.; Park, J.; Chung, H. K.; Lee, J. S.; Lee, J. S.; Park, H. J.; Song, S. Y. et al. Use of Macrophages to Deliver Therapeutic and Imaging Contrast Agents to Tumors Biomaterials 2012, 33, 4195-4203
42. Alizadeh, D.; Zhang, L.; Hwang, J.; Schluep, T.; Badie, B. Tumor-Associated Macrophages Are Predominant Carriers of Cyclodextrin-Based Nanoparticles into Gliomas Nanomedicine 2010, 6, 382-390
43. Champion, J. A.; Mitragotri, S. Role of Target Geometry in Phagocytosis Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 4930-4934
44. Yu, S. S.; Lau, C. M.; Thomas, S. N.; Jerome, W. G.; Maron, D. J.; Dickerson, J. H.; Hubbell, J. A.; Giorgio, T. D. Size- and Charge-Dependent Non-Specific Uptake of PEGylated Nanoparticles by Macrophages Int. J. Nanomed. 2012, 7, 799-813
45. Fröhlich, E. The Role of Surface Charge in Cellular Uptake and Cytotoxicity of Medical Nanoparticles Int. J. Nanomed. 2012, 7, 5577-5591
46. Hasegawa, T.; Hirota, K.; Tomoda, K.; Ito, F.; Inagawa, H.; Kochi, C.; Soma, G.-I.; Makino, K.; Terada, H. Phagocytic Activity of Alveolar Macrophages toward Polystyrene Latex Microspheres and PLGA Microspheres Loaded with Anti-Tuberculosis Agent Colloids Surf. B: Biointerfaces 2007, 60, 221-228
47. Takano, S.; Aramaki, Y.; Tsuchiya, S. Physicochemical Properties of Liposomes Affecting Apoptosis Induced by Cationic Liposomes in Macrophages Pharm. Res. 2003, 20, 962-968
48. Champion, J. A.; Walker, A.; Mitragotri, S. Role of Particle Size in Phagocytosis of Polymeric Microspheres Pharm. Res. 2008, 25, 1815-1821
49. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery J. Controlled Release 2006, 114, 100-109
50. Tomita, Y.; Rikimaru-Kaneko, A.; Hashiguchi, K.; Shirotake, S. Effect of Anionic and Cationic N-Butylcyanoacrylate Nanoparticles on NO and Cytokine Production in Raw264.7 Cells Immunopharmacol. Immunotoxicol. 2011, 33, 730-737
51. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev. 2001, 53, 283-318
52. Dolina, J. S.; Sung, S.-S. J.; Novobrantseva, T. I.; Nguyen, T. M.; Hahn, Y. S. Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-Mediated Hepatic Antiviral Immunity Mol. Ther. Nucleic Acids 2013, 2, e72
53. Fife, B. T.; Pauken, K. E.; Eagar, T. N.; Obu, T.; Wu, J.; Tang, Q.; Azuma, M.; Krummel, M. F.; Bluestone, J. A. Interactions between PD-1 and PD-L1 Promote Tolerance by Blocking the TCR-Induced Stop Signal Nat. Immunol. 2009, 10, 1185-1192
54. Alvarez, I. B.; Pasquinelli, V.; Jurado, J. O.; Abbate, E.; Musella, R. M.; de la Barrera, S. S.; García, V. E. Role Played by the Programmed Death-1-Programmed Death Ligand Pathway during Innate Immunity against Mycobacterium Tuberculosis J. Infect. Dis. 2010, 202, 524-532
55. Benson, D. M.; Bakan, C. E.; Mishra, A.; Hofmeister, C. C.; Efebera, Y.; Becknell, B.; Baiocchi, R. A.; Zhang, J.; Yu, J.; Smith, M. K. et al. The PD-1/PD-L1 Axis Modulates the Natural Killer Cell versus Multiple Myeloma Effect: A Therapeutic Target for CT-011, a Novel Monoclonal Anti-PD-1 Antibody Blood 2010, 116, 2286-2294
56. Okazaki, T.; Honjo, T. The PD-1-PD-L Pathway in Immunological Tolerance Trends Immunol. 2006, 27, 195-201
57. Leuschner, F.; Dutta, P.; Gorbatov, R.; Novobrantseva, T. I.; Donahoe, J. S.; Courties, G.; Lee, K. M.; Kim, J. I.; Markmann, J. F.; Marinelli, B. et al. Therapeutic siRNA Silencing in Inflammatory Monocytes in Mice Nat. Biotechnol. 2011, 29, 1005-1010
58. Duivenvoorden, R.; Tang, J.; Cormode, D. P.; Mieszawska, A. J.; Izquierdo-Garcia, D.; Ozcan, C.; Otten, M. J.; Zaidi, N.; Lobatto, M. E.; van Rijs, S. M. et al. A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation Nat. Commun. 2014, 5, 3065
59. Beduneau, A.; Ma, Z.; Grotepas, C. B.; Kabanov, A.; Rabinow, B. E.; Gong, N.; Mosley, R. L.; Dou, H.; Boska, M. D.; Gendelman, H. E. Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles PLoS One 2009, 4, 1-12
60. Laroui, H.; Viennois, E.; Xiao, B.; Canup, B. S. B.; Geem, D.; Denning, T. L.; Merlin, D. Fab-Bearing siRNA TNFα-Loaded Nanoparticles Targeted to Colonic Macrophages Offer an Effective Therapy for Experimental Colitis J. Controlled Release 2014, 186, 41-53
61. Wijagkanalan, W.; Kawakami, S.; Higuchi, Y.; Yamashita, F.; Hashida, M. Intratracheally Instilled Mannosylated Cationic liposome/NFκB Decoy Complexes for Effective Prevention of LPS-Induced Lung Inflammation J. Controlled Release 2011, 149, 42-50
62. Movahedi, K.; Laoui, D.; Gysemans, C.; Baeten, M.; Stangé, G.; Van den Bossche, J.; Mack, M.; Pipeleers, D.; Int Veld, P.; De Baetselier, P. et al. Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes Cancer Res. 2010, 70, 5728-5739
63. Locke, L. W.; Mayo, M. W.; Yoo, A. D.; Williams, M. B.; Berr, S. S. PET Imaging of Tumor Associated Macrophages Using Mannose Coated 64Cu Liposomes Biomaterials 2012, 33, 7785-7793
64. Liu, Z.; Cai, W.; He, L.; Nakayama, N.; Chen, K.; Sun, X.; Chen, X.; Dai, H. In Vivo Biodistribution and Highly Efficient Tumour Targeting of Carbon Nanotubes in Mice Nat. Nanotechnol. 2007, 2, 47-52
65. Maeda, H. The Enhanced Permeability and Retention (EPR) Effect in Tumor Vasculature: The Key Role of Tumor-Selective Macromolecular Drug Targeting Adv. Enzyme Regul. 2001, 41, 189-207
66. Smith, B. R.; Zavaleta, C.; Rosenberg, J.; Tong, R.; Ramunas, J.; Liu, Z.; Dai, H.; Gambhir, S. S. High-Resolution, Serial Intravital Microscopic Imaging of Nanoparticle Delivery and Targeting in a Small Animal Tumor Model. Nano Today 2013, 8.
67. Smith, B. R.; Ghosn, E. E. B.; Rallapalli, H.; Prescher, J. A.; Larson, T.; Herzenberg, L. A.; Gambhir, S. S. Selective Uptake of Single-Walled Carbon Nanotubes by Circulating Monocytes for Enhanced Tumour Delivery Nat. Nanotechnol. 2014, 9, 481-487
68. Kolaczkowska, E.; Kubes, P. Neutrophil Recruitment and Function in Health and Inflammation Nat. Rev. Immunol. 2013, 13, 159-175
69. Wright, H. L.; Moots, R. J.; Bucknall, R. C.; Edwards, S. W. Neutrophil Function in Inflammation and Inflammatory Diseases Rheumatology (Oxford) 2010, 49, 1618-1631
70. Wang, Z.; Li, J.; Cho, J.; Malik, A. B. Prevention of Vascular Inflammation by Nanoparticle Targeting of Adherent Neutrophils Nat. Nanotechnol. 2014, 9, 204-210
71. Kamaly, N.; Fredman, G.; Subramanian, M.; Gadde, S.; Pesic, A.; Cheung, L.; Fayad, Z. A.; Langer, R.; Tabas, I.; Farokhzad, O. C. Development and in Vivo Efficacy of Targeted Polymeric Inflammation-Resolving Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 6506-6511
72. Tsai, S.; Santamaria, P. MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity Front. Immunol. 2013, 4, 321
73. Maus, M. V.; Fraietta, J. A.; Levine, B. L.; Kalos, M.; Zhao, Y.; June, C. H. Adoptive Immunotherapy for Cancer or Viruses Annu. Rev. Immunol. 2014, 32, 189-225
74. Perica, K.; Tu, A.; Richter, A.; Bieler, J. G.; Edidin, M.; Schneck, J. P. Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity ACS Nano 2015, 8, 2252-2260
75. Yee, C.; Thompson, J. A.; Byrd, D.; Riddell, S. R.; Roche, P.; Celis, E.; Greenberg, P. D. Adoptive T Cell Therapy Using Antigen-Specific CD8+ T Cell Clones for the Treatment of Patients with Metastatic Melanoma: In Vivo Persistence, Migration, and Antitumor Effect of Transferred T Cells Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 16168-16173
76. Rosalia, R. A.; Arenas-Ramirez, N.; Bouchaud, G.; Raeber, M. E.; Boyman, O. Use of Enhanced Interleukin-2 Formulations for Improved Immunotherapy against Cancer Curr. Opin. Chem. Biol. 2014, 23, 39-46
77. Zeng, R.; Spolski, R.; Finkelstein, S. E.; Oh, S.; Kovanen, P. E.; Hinrichs, C. S.; Pise-Masison, C. A.; Radonovich, M. F.; Brady, J. N.; Restifo, N. P. et al. Synergy of IL-21 and IL-15 in Regulating CD8+ T Cell Expansion and Function J. Exp. Med. 2005, 201, 139-148
78. Panelli, M. C.; White, R.; Foster, M.; Martin, B.; Wang, E.; Smith, K.; Marincola, F. M. Forecasting the Cytokine Storm Following Systemic Interleukin (IL)-2 Administration J. Transl. Med. 2004, 2, 17
79. Stephan, M. T.; Moon, J. J.; Um, S. H.; Bershteyn, A.; Irvine, D. J. Therapeutic Cell Engineering with Surface-Conjugated Synthetic Nanoparticles Nat. Med. 2010, 16, 1035-1041
80. Stephan, M. T.; Stephan, S. B.; Bak, P.; Chen, J.; Irvine, D. J. Synapse-Directed Delivery of Immunomodulators Using T-Cell-Conjugated Nanoparticles Biomaterials 2012, 33, 5776-5787
81. Vinay, D. S.; Kwon, B. S. Role of 4-1BB in Immune Responses Semin. Immunol. 1998, 10, 481-489
82. Park, J.; Wrzesinski, S. H.; Stern, E.; Look, M.; Criscione, J.; Ragheb, R.; Jay, S. M.; Demento, S. L.; Agawu, A.; Licona Limon, P. et al. Combination Delivery of TGF-B Inhibitor and IL-2 by Nanoscale Liposomal Polymeric Gels Enhances Tumour Immunotherapy Nat. Mater. 2012, 11, 895-905
83. Zheng, Y.; Stephan, M. T.; Gai, S. A.; Abraham, W.; Shearer, A.; Irvine, D. J. In Vivo Targeting of Adoptively Transferred T-Cells with Antibody- and Cytokine-Conjugated Liposomes J. Controlled Release 2013, 172, 426-435
84. Ni, X.; Castanares, M.; Mukherjee, A.; Lupold, S. E. Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons Curr. Med. Chem. 2011, 18, 4206-4214
85. McNamara, J. O.; Kolonias, D.; Pastor, F.; Mittler, R. S.; Chen, L.; Giangrande, P. H.; Sullenger, B.; Gilboa, E. Multivalent 4-1BB Binding Aptamers Costimulate CD8+ T Cells and Inhibit Tumor Growth in Mice J. Clin. Invest. 2008, 118, 376-386
86. Xing, Y.; Hogquist, K. A. T-Cell Tolerance: Central and Peripheral Cold Spring Harbor Perspect. Biol. 2012, 4, a006957
87. Tsai, S.; Shameli, A.; Yamanouchi, J.; Clemente-Casares, X.; Wang, J.; Serra, P.; Yang, Y.; Medarova, Z.; Moore, A.; Santamaria, P. Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells Immunity 2010, 32, 568-580
88. Beeton, C.; Wulff, H.; Standifer, N. E.; Azam, P.; Mullen, K. M.; Pennington, M. W.; Kolski-Andreaco, A.; Wei, E.; Grino, A.; Counts, D. R. et al. Kv1.3 Channels Are a Therapeutic Target for T Cell-Mediated Autoimmune Diseases Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 17414-17419
89. Hajdu, P.; Chimote, A. A.; Thompson, T. H.; Koo, Y.; Yun, Y.; Conforti, L. Functionalized Liposomes Loaded with siRNAs Targeting Ion Channels in Effector Memory T Cells as a Potential Therapy for Autoimmunity Biomaterials 2013, 34, 10249-10257
90. Fahmy, T. M.; Schneck, J. P.; Saltzman, W. M. A Nanoscopic Multivalent Antigen-Presenting Carrier for Sensitive Detection and Drug Delivery to T Cells Nanomedicine 2007, 3, 75-85
91. Park, J.; Gao, W.; Whiston, R.; Strom, T. B.; Metcalfe, S.; Fahmy, T. M. Modulation of CD4+ T Lymphocyte Lineage Outcomes with Targeted, Nanoparticle-Mediated Cytokine Delivery Mol. Pharmaceutics 2011, 8, 143-152
92. Endsley, A. N.; Ho, R. J. Y. Enhanced Anti-HIV Efficacy of Indinavir after Inclusion in CD4-Targeted Lipid Nanoparticles J. Acquir. Immune Defic. Syndr. 2012, 61, 417-424
93. Perisé-Barrios, A. J.; Jiménez, J. L.; Domínguez-Soto, A.; de la Mata, F. J.; Corbí, A. L.; Gomez, R.; Muñoz-Fernandez, M. á. Carbosilane Dendrimers as Gene Delivery Agents for the Treatment of HIV Infection J. Controlled Release 2014, 184, 51-57
94. Serramía, M. J.; álvarez, S.; Fuentes-Paniagua, E.; Clemente, M. I.; Sánchez-Nieves, J.; Gómez, R.; de la Mata, J.; Muñoz-Fernández, M. á. In Vivo Delivery of siRNA to the Brain by Carbosilane Dendrimer J. Controlled Release 2015, 200C, 60-70
95. Kim, Y.-M.; Pan, J. Y.-J.; Korbel, G. a; Peperzak, V.; Boes, M.; Ploegh, H. L. Monovalent Ligation of the B Cell Receptor Induces Receptor Activation but Fails to Promote Antigen Presentation Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 3327-3332
96. Minguet, S.; Dopfer, E. P.; Schamel, W. W. A. Low-Valency, but Not Monovalent, Antigens Trigger the B-Cell Antigen Receptor (BCR) Int. Immunol. 2010, 22, 205-212
97. Bachmann, M. F.; Hoffman Rohrer, U.; Kundig, T. M.; Burki, K.; Hengartner, H.; Zinkernagel, R. M. The Influence of Antigen Organization on B Cell Responsiveness Science 1993, 262, 1448-1451
98. Pasare, C.; Medzhitov, R. Control of B-Cell Responses by Toll-like Receptors Nature 2005, 438, 364-368
99. Minguet, S.; Dopfer, E. P.; Pollmer, C.; Freudenberg, M. A.; Galanos, C.; Reth, M.; Huber, M.; Schamel, W. W. Enhanced B-Cell Activation Mediated by TLR4 and BCR Crosstalk Eur. J. Immunol. 2008, 38, 2475-2487
100. Dintzis, R. Z.; Middleton, M. H.; Dintzis, H. M. Studies on the Immunogenicity and Tolerogenicity of T-Independent Antigens J. Immunol. 1983, 131, 2196-2203
101. Dintzis, H. M.; Dintzis, R. Z.; Vogelstein, B. Molecular Determinants of Immunogenicity: The Immunon Model of Immune Response Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 3671-3675
102. Chackerian, B.; Durfee, M. R.; Schiller, J. T. Anergy in a B Cell Receptor Transgenic Mouse Model 1 J. Immunol. 2011, 2008, 5816-5825
103. Chackerian, B.; Lowy, D. R.; Schiller, J. T. Conjugation of a Self-Antigen to Papillomavirus-like Particles Allows for Efficient Induction of Protective Autoantibodies J. Clin. Invest. 2001, 108, 415-423
104. Gatto, D.; Martin, S. W.; Bessa, J.; Pellicioli, E.; Saudan, P.; Hinton, H. J.; Bachmann, M. F. Regulation of Memory Antibody Levels: The Role of Persisting Antigen versus Plasma Cell Life Span J. Immunol. 2007, 178, 67-76
105. Zeltins, A. Construction and Characterization of Virus-like Particles: A Review Mol. Biotechnol. 2013, 53, 92-107
106. Lico, C.; Marusic, C.; Capuano, F.; Buriani, G.; Benvenuto, E.; Baschieri, S. Innovation in Vaccinology; Springer Science+Business Media B.V., GX Dordrecht, Netherlands, 2012.
107. Rodríguez-Limas, W. a.; Sekar, K.; Tyo, K. E. J. Virus-like Particles: The Future of Microbial Factories and Cell-Free Systems as Platforms for Vaccine Development Curr. Opin. Biotechnol. 2013, 24, 1089-1093
108. Chang, L.-J.; Dowd, K. A.; Mendoza, F. H.; Saunders, J. G.; Sitar, S.; Plummer, S. H.; Yamshchikov, G.; Sarwar, U. N.; Hu, Z.; Enama, M. E. et al. Safety and Tolerability of Chikungunya Virus-like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial Lancet 2014, 384, 2046-2052
109. Mbow, M. L.; De Gregorio, E.; Valiante, N. M.; Rappuoli, R. New Adjuvants for Human Vaccines Curr. Opin Immunol 2010, 22, 411-416
110. Morefield, G. L.; Sokolovska, A.; Jiang, D.; Hogenesch, H.; Robinson, J. P.; Hem, S. L. Role of Aluminum-Containing Adjuvants in Antigen Internalization by Dendritic Cells in Vitro Vaccine 2005, 23, 1588-1595
111. Xiao, Y.; Zeng, Y.; Alexander, E.; Mehta, S.; Joshi, S. B.; Buchman, G. W.; Volkin, D. B.; Middaugh, C. R.; Isaacs, S. N. Adsorption of Recombinant Poxvirus L1-Protein to Aluminum hydroxide/CpG Vaccine Adjuvants Enhances Immune Responses and Protection of Mice from Vaccinia Virus Challenge Vaccine 2013, 31, 319-326
112. Watson, D. S.; Endsley, A. N.; Huang, L. Design Considerations for Liposomal Vaccines: Influence of Formulation Parameters on Antibody and Cell-Mediated Immune Responses to Liposome Associated Antigens Vaccine 2012, 30, 2256-2272
113. Sah, H.; Thoma, L. A.; Desu, H. R.; Sah, E.; Wood, G. C. Concepts and Practices Used to Develop Functional PLGA-Based Nanoparticulate Systems Int. J. Nanomed. 2013, 8, 747-765
114. Moyle, P. M.; Toth, I. Modern Subunit Vaccines: Development, Components, and Research Opportunities ChemMedChem 2013, 8, 360-376
115. Friede, M.; Muller, S.; Briand, J. P.; Van Regenmortel, M. H.; Schuber, F. Induction of Immune Response against a Short Synthetic Peptide Antigen Coupled to Small Neutral Liposomes Containing Monophosphoryl Lipid A Mol. Immunol. 1993, 30, 539-547
116. Temchura, V. V.; Kozlova, D.; Sokolova, V.; Überla, K.; Epple, M. Targeting and Activation of Antigen-Specific B-Cells by Calcium Phosphate Nanoparticles Loaded with Protein Antigen Biomaterials 2014, 35, 6098-6105
117. Stefanick, J. F.; Ashley, J. D.; Kiziltepe, T.; Bilgicer, B. A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes ACS Nano 2013, 7, 2935-2947
118. Stefanick, J. F.; Ashley, J. D.; Bilgicer, B. Enhanced Cellular Uptake of Peptide-Targeted Nanoparticles through Increased Peptide Hydrophilicity and Optimized Ethylene Glycol Peptide-Linker Length ACS Nano 2013, 7, 8115-8127
119. Bershteyn, A.; Hanson, M. C.; Crespo, M. P.; Moon, J. J.; Li, A. V.; Suh, H.; Irvine, D. J. Robust IgG Responses to Nanograms of Antigen Using a Biomimetic Lipid-Coated Particle Vaccine J. Controlled Release 2012, 157, 354-365
120. Moon, J. J.; Suh, H.; Polhemus, M. E.; Ockenhouse, C. F.; Yadava, A.; Irvine, D. J. Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium Vivax Malaria Vaccine PLoS One 2012, 7, e31472
121. Torres, A. G.; Gregory, A. E.; Hatcher, C. L.; Vinet-Oliphant, H.; Morici, L. A.; Titball, R. W.; Roy, C. J. Protection of Non-Human Primates against Glanders with a Gold Nanoparticle Glycoconjugate Vaccine Vaccine 2015, 33, 686-692
122. Iwasaki, A. Antiviral Immune Responses in the Genital Tract: Clues for Vaccines Nat. Rev. Immunol. 2010, 10, 699-711
123. Iwasaki, A. Mucosal Dendritic Cells Annu. Rev. Immunol. 2007, 25, 381-418
124. Clark, R. A. Resident Memory T Cells in Human Health and Disease Sci. Transl. Med. 2015, 7, 269rv1-rv269rv1
125. Waeckerle-Men, Y.; Bruffaerts, N.; Liang, Y.; Jurion, F.; Sander, P.; Kündig, T. M.; Huygen, K.; Johansen, P. Lymph Node Targeting of BCG Vaccines Amplifies CD4 and CD8 T-Cell Responses and Protection against Mycobacterium Tuberculosis Vaccine 2013, 31, 1057-1064
126. Weber, J.; Boswell, W.; Smith, J.; Hersh, E.; Snively, J.; Diaz, M.; Miles, S.; Liu, X.; Obrocea, M.; Qiu, Z.; et al., Phase 1 Trial of Intranodal Injection of a Melan-A/MART-1 DNA Plasmid Vaccine in Patients with Stage IV Melanoma. J. Immunother. 31, 215-223.
127. Maier, T.; Tun-Kyi, A.; Tassis, A.; Jungius, K.-P.; Burg, G.; Dummer, R.; Nestle, F. O. Vaccination of Patients with Cutaneous T-Cell Lymphoma Using Intranodal Injection of Autologous Tumor-Lysate-Pulsed Dendritic Cells Blood 2003, 102, 2338-2344
128. Gilliet, M.; Kleinhans, M.; Lantelme, E.; Schadendorf, D.; Burg, G.; Nestle, F. O. Intranodal Injection of Semimature Monocyte-Derived Dendritic Cells Induces T Helper Type 1 Responses to Protein Neoantigen Blood 2003, 102, 36-42
129. Adamina, M.; Rosenthal, R.; Weber, W. P.; Frey, D. M.; Viehl, C. T.; Bolli, M.; Huegli, R. W.; Jacob, A. L.; Heberer, M.; Oertli, D. et al. Intranodal Immunization with a Vaccinia Virus Encoding Multiple Antigenic Epitopes and Costimulatory Molecules in Metastatic Melanoma Mol. Ther. 2010, 18, 651-659
130. Silva, A. L.; Rosalia, R. A.; Varypataki, E.; Sibuea, S.; Ossendorp, F.; Jiskoot, W. Poly-(lactic-Co-Glycolic-Acid)-Based Particulate Vaccines: Particle Uptake by Dendritic Cells Is a Key Parameter for Immune Activation Vaccine 2015, 33, 847-854
131. Jewell, C. M.; Bustamante Lopez, S. C.; Irvine, D. J. In Situ Engineering of the Lymph Node Microenvironment via Intranodal Injection of Adjuvant-Releasing Polymer Particles Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 15745-15750
132. Slütter, B.; Bal, S. M.; Ding, Z.; Jiskoot, W.; Bouwstra, J. A. Adjuvant Effect of Cationic Liposomes and CpG Depends on Administration Route J. Controlled Release 2011, 154, 123-130
133. Kaminskas, L. M.; Porter, C. J. H. Targeting the Lymphatics Using Dendritic Polymers (dendrimers) Adv. Drug Delivery Rev. 2011, 63, 890-900
134. Manolova, V.; Flace, A.; Bauer, M.; Schwarz, K.; Saudan, P.; Bachmann, M. F. Nanoparticles Target Distinct Dendritic Cell Populations according to Their Size Eur. J. Immunol. 2008, 38, 1404-1413
135. Reddy, S. T.; van der Vlies, A. J.; Simeoni, E.; Angeli, V.; Randolph, G. J.; ONeil, C. P.; Lee, L. K.; Swartz, M. A.; Hubbell, J. A. Exploiting Lymphatic Transport and Complement Activation in Nanoparticle Vaccines Nat. Biotechnol. 2007, 25, 1159-1164
136. Reddy, S. T.; Rehor, A.; Schmoekel, H. G.; Hubbell, J. A.; Swartz, M. A. In Vivo Targeting of Dendritic Cells in Lymph Nodes with Poly(propylene Sulfide) Nanoparticles J. Controlled Release 2006, 112, 26-34
137. Kourtis, I. C.; Hirosue, S.; de Titta, A.; Kontos, S.; Stegmann, T.; Hubbell, J. A.; Swartz, M. A. Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice PLoS One 2013, 8, e61646
138. Fifis, T.; Gamvrellis, A.; Crimeen-Irwin, B.; Pietersz, G. A.; Li, J.; Mottram, P. L.; McKenzie, I. F. C.; Plebanski, M. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors J. Immunol. 2004, 173, 3148-3154
139. Fifis, T.; Mottram, P.; Bogdanoska, V.; Hanley, J.; Plebanski, M. Short Peptide Sequences Containing MHC Class I And/or Class II Epitopes Linked to Nano-Beads Induce Strong Immunity and Inhibition of Growth of Antigen-Specific Tumour Challenge in Mice Vaccine 2004, 23, 258-266
140. Gerner, M. Y.; Torabi-Parizi, P.; Germain, R. N. Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens Immunity 2014, 42, 172-185
141. Mueller, S. N.; Tian, S.; DeSimone, J. M. Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity Mol. Pharmaceutics 2015, 12, 1356-1365
142. Hanson, M. C.; Abraham, W.; Crespo, M. P.; Chen, S. H.; Liu, H.; Szeto, G. L.; Kim, M.; Reinherz, E. L.; Irvine, D. J. Liposomal Vaccines Incorporating Molecular Adjuvants and Intrastructural T-Cell Help Promote the Immunogenicity of HIV Membrane-Proximal External Region Peptides Vaccine 2015, 33, 861-868
143. Oussoren, C.; Zuidema, J.; Crommelin, D. J. A.; Storm, G. Lymphatic Uptake and Biodistribution of Liposomes after Subcutaneous Injection. II. Influence of Liposomal Size, Lipid Composition and Lipid Dose Biochim. Biophys. Acta: Biomembr. 1997, 1328, 261-272
144. Oyewumi, M. O.; Kumar, A.; Cui, Z. Nano-Microparticles as Immune Adjuvants: Correlating Particle Sizes and the Resultant Immune Responses Expert Rev. Vaccines 2010, 9, 1095-1107
145. Yan, S.; Gu, W.; Xu, Z. P. Re-Considering How Particle Size and Other Properties of Antigen-Adjuvant Complexes Impact on the Immune Responses J. Colloid Interface Sci. 2013, 395, 1-10
146. Smirnov, D.; Schmidt, J. J.; Capecchi, J. T.; Wightman, P. D. Vaccine Adjuvant Activity of 3m-052: An Imidazoquinoline Designed for Local Activity without Systemic Cytokine Induction Vaccine 2011, 29, 5434-5442
147. Ilyinskii, P. O.; Roy, C. J.; ONeil, C. P.; Browning, E. a; Pittet, L. a; Altreuter, D. H.; Alexis, F.; Tonti, E.; Shi, J.; Basto, P. a; et al. Adjuvant-Carrying Synthetic Vaccine Particles Augment the Immune Response to Encapsulated Antigen and Exhibit Strong Local Immune Activation without Inducing Systemic Cytokine Release Vaccine 2014, 32, 2882-2895
148. Kinman, L.; Brodie, S. J.; Tsai, C. C.; Bui, T.; Larsen, K.; Schmidt, A.; Anderson, D.; Morton, W. R.; Hu, S.-L.; Ho, R. J. Y. Lipid-Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques J. Acquired Immune Defic. Syndr. 2003, 34, 387-397
149. Freeling, J. P.; Ho, R. J. Y. Anti-HIV Drug Particles May Overcome Lymphatic Drug Insufficiency and Associated HIV Persistence Proc. Natl. Acad. Sci. U.S.A. 2014, 111, E2512-E2513
150. Junt, T.; Moseman, E. A.; Iannacone, M.; Massberg, S.; Lang, P. a; Boes, M.; Fink, K.; Henrickson, S. E.; Shayakhmetov, D. M.; Di Paolo, N. C. et al. Subcapsular Sinus Macrophages in Lymph Nodes Clear Lymph-Borne Viruses and Present Them to Antiviral B Cells Nature 2007, 450, 110-114
151. Carrasco, Y. R.; Batista, F. D. B Cells Acquire Particulate Antigen in a Macrophage-Rich Area at the Boundary between the Follicle and the Subcapsular Sinus of the Lymph Node Immunity 2007, 27, 160-171
152. Phan, T. G.; Grigorova, I.; Okada, T.; Cyster, J. G. Subcapsular Encounter and Complement-Dependent Transport of Immune Complexes by Lymph Node B Cells Nat. Immunol. 2007, 8, 992-1000
153. Moon, J. J.; Suh, H.; Li, A. V.; Ockenhouse, C. F.; Yadava, A.; Irvine, D. J. Enhancing Humoral Responses to a Malaria Antigen with Nanoparticle Vaccines That Expand Tfh Cells and Promote Germinal Center Induction Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 1080-1085
154. Wang, C.; Liu, P.; Zhuang, Y.; Li, P.; Jiang, B.; Pan, H.; Liu, L.; Cai, L.; Ma, Y. Lymphatic-Targeted Cationic Liposomes: A Robust Vaccine Adjuvant for Promoting Long-Term Immunological Memory Vaccine 2014, 32, 5475-5483
155. Cruz, L. J.; Rosalia, R. A.; Kleinovink, J. W.; Rueda, F.; Löwik, C. W. G. M.; Ossendorp, F. Targeting Nanoparticles to CD40, DEC-205 or CD11c Molecules on Dendritic Cells for Efficient CD8(+) T Cell Response: A Comparative Study J. Controlled Release 2014, 192, 209-218
156. Rosalia, R. A.; Cruz, L. J.; Duikeren, S. Van; Tromp, A. T.; Oostendorp, J.; Silva, A. L.; Jiskoot, W.; Gruijl, T. De; Clemens, L.; van der Burg, S. H. et al. CD40-Targeted Dendritic Cell Delivery of PLGA-Nanoparticle Vaccines Induce Potent Anti-Tumor Responses Biomaterials 2015, 40, 88-97
157. Muraoka, D.; Harada, N.; Hayashi, T.; Tahara, Y.; Momose, F.; Sawada, S.; Mukai, S.; Akiyoshi, K.; Shiku, H. Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity ACS Nano 2014, 8, 9209-9218
158. Cerutti, A.; Chen, K.; Chorny, A. Immunoglobulin Responses at the Mucosal Interface Annu. Rev. Immunol. 2011, 29, 273-293
159. Brandtzaeg, P. Induction of Secretory Immunity and Memory at Mucosal Surfaces Vaccine 2007, 25, 5467-5484
160. Hanniffy, S. B.; Carter, A. T.; Hitchin, E.; Wells, J. M. Mucosal Delivery of a Pneumococcal Vaccine Using Lactococcus Lactis Affords Protection against Respiratory Infection J. Infect. Dis. 2007, 195, 185-193
161. Ralli-Jain, P.; Tifrea, D.; Cheng, C.; Pal, S.; de la Maza, L. M. Enhancement of the Protective Efficacy of a Chlamydia Trachomatis Recombinant Vaccine by Combining Systemic and Mucosal Routes for Immunization Vaccine 2010, 28, 7659-7666
162. Kuznetsov, V. A.; Stepanov, V. S.; Berzofsky, J. A.; Belyakov, I. M. Assessment of the Relative Therapeutic Effects of Vaccines on Virus Load and Immune Responses in Small Groups at Several Time Points: Efficacy of Mucosal and Subcutaneous Polypeptide Vaccines in Rhesus Macaques Exposed to SHIV J. Clin. Virol. 2004, 31 (Suppl 1) S69-S82
163. Gebril, A.; Alsaadi, M.; Acevedo, R.; Mullen, A. B.; Ferro, V. A. Optimizing Efficacy of Mucosal Vaccines Expert Rev. Vaccines 2012, 11, 1139-1155
164. Woodrow, K. a.; Bennett, K. M.; Lo, D. D. Mucosal Vaccine Design and Delivery Annu. Rev. Biomed. Eng. 2012, 14, 17-46
165. Riese, P.; Sakthivel, P.; Trittel, S.; Guzmán, C. A. Intranasal Formulations: Promising Strategy to Deliver Vaccines Expert Opin. Drug Delivery 2014, 11, 1619-1634
166. Okada, E.; Sasaki, S.; Ishii, N.; Aoki, I.; Yasuda, T.; Nishioka, K.; Fukushima, J.; Miyazaki, J.; Wahren, B.; Okuda, K. Intranasal Immunization of a DNA Vaccine with IL-12- and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Expressing Plasmids in Liposomes Induces Strong Mucosal and Cell-Mediated Immune Responses against HIV-1 Antigens J. Immunol. 1997, 159, 3638-3647
167. Klavinskis, L. S.; Barnfield, C.; Gao, L.; Parker, S. Intranasal Immunization with Plasmid DNA-Lipid Complexes Elicits Mucosal Immunity in the Female Genital and Rectal Tracts J. Immunol. 1999, 162, 254-262
168. Thornton, E. E.; Looney, M. R.; Bose, O.; Sen, D.; Sheppard, D.; Locksley, R.; Huang, X.; Krummel, M. F. Spatiotemporally Separated Antigen Uptake by Alveolar Dendritic Cells and Airway Presentation to T Cells in the Lung J. Exp. Med. 2012, 209, 1183-1199
169. Li, A. V.; Moon, J. J.; Abraham, W.; Suh, H.; Elkhader, J.; Seidman, M. a; Yen, M.; Im, E.-J.; Foley, M. H.; Barouch, D. H. et al. Generation of Effector Memory T Cell-Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination Sci. Transl. Med. 2013, 5, 204ra130
170. Vicente, S.; Peleteiro, M.; Díaz-Freitas, B.; Sanchez, A.; González-Fernández, á.; Alonso, M. J. Co-Delivery of Viral Proteins and a TLR7 Agonist from Polysaccharide Nanocapsules: A Needle-Free Vaccination Strategy J. Controlled Release 2013, 172, 773-781
171. Sanders, M. T.; Deliyannis, G.; Pearse, M. J.; McNamara, M. K.; Brown, L. E. Single Dose Intranasal Immunization with ISCOMATRIX Vaccines to Elicit Antibody-Mediated Clearance of Influenza Virus Requires Delivery to the Lower Respiratory Tract Vaccine 2009, 27, 2475-2482
172. Nochi, T.; Yuki, Y.; Takahashi, H.; Sawada, S.; Mejima, M.; Kohda, T.; Harada, N.; Kong, I. G.; Sato, A.; Kataoka, N. et al. Nanogel Antigenic Protein-Delivery System for Adjuvant-Free Intranasal Vaccines Nat. Mater. 2010, 9, 572-578
173. Maisel, K.; Ensign, L.; Reddy, M.; Cone, R.; Hanes, J. Effect of Surface Chemistry on Nanoparticle Interaction with Gastrointestinal Mucus and Distribution in the Gastrointestinal Tract Following Oral and Rectal Administration in the Mouse J. Controlled Release 2015, 197, 48-57
174. Cu, Y.; Booth, C. J.; Saltzman, W. M. In Vivo Distribution of Surface-Modified PLGA Nanoparticles Following Intravaginal Delivery J. Controlled Release 2011, 156, 258-264
175. Stano, A.; van der Vlies, A. J.; Martino, M. M.; Swartz, M. A.; Hubbell, J. A.; Simeoni, E. PPS Nanoparticles as Versatile Delivery System to Induce Systemic and Broad Mucosal Immunity after Intranasal Administration Vaccine 2011, 29, 804-812
176. Nembrini, C.; Stano, A.; Dane, K. Y.; Ballester, M.; van der Vlies, A. J.; Marsland, B. J.; Swartz, M. A.; Hubbell, J. A. Nanoparticle Conjugation of Antigen Enhances Cytotoxic T-Cell Responses in Pulmonary Vaccination Proc. Natl. Acad. Sci. U.S.A. 2011, 108, E989-E997
177. Stano, A.; Nembrini, C.; Swartz, M. A.; Hubbell, J. A.; Simeoni, E. Nanoparticle Size Influences the Magnitude and Quality of Mucosal Immune Responses after Intranasal Immunization Vaccine 2012, 30, 7541-7546
178. Stylianou, E.; Diogo, G. R.; Pepponi, I.; van Dolleweerd, C.; Arias, M. A.; Locht, C.; Rider, C. C.; Sibley, L.; Cutting, S. M.; Loxley, A. et al. Mucosal Delivery of Antigen-Coated Nanoparticles to Lungs Confers Protective Immunity against Tuberculosis Infection in Mice Eur. J. Immunol. 2014, 44, 440-449
179. Yeh, T.-H.; Hsu, L.-W.; Tseng, M. T.; Lee, P.-L.; Sonjae, K.; Ho, Y.-C.; Sung, H.-W. Mechanism and Consequence of Chitosan-Mediated Reversible Epithelial Tight Junction Opening Biomaterials 2011, 32, 6164-6173
180. Fernandez-Urrusuno, R.; Calvo, P.; Remunan-Lopez, C.; Vila-Jato, J.; Alonso, M. Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles Pharm. Res. 1999, 16, 1576-1581
181. Xu, J.; Dai, W.; Wang, Z.; Chen, B.; Li, Z.; Fan, X. Intranasal Vaccination with Chitosan-DNA Nanoparticles Expressing Pneumococcal Surface Antigen a Protects Mice against Nasopharyngeal Colonization by Streptococcus Pneumoniae Clin. Vaccine Immunol. 2011, 18, 75-81
182. Sawaengsak, C.; Mori, Y.; Yamanishi, K.; Mitrevej, A.; Sinchaipanid, N. Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine AAPS PharmSciTech 2014, 15, 317-325
183. Bal, S. M.; Slütter, B.; Verheul, R.; Bouwstra, J. a.; Jiskoot, W. Adjuvanted, Antigen Loaded N-Trimethyl Chitosan Nanoparticles for Nasal and Intradermal Vaccination: Adjuvant- and Site-Dependent Immunogenicity in Mice Eur. J. Pharm. Sci. 2012, 45, 475-481
184. Davis, M. J.; Swanson, J. A. Technical Advance: Caspase-1 Activation and IL-1β Release Correlate with the Degree of Lysosome Damage, as Illustrated by a Novel Imaging Method to Quantify Phagolysosome Damage J. Leukocyte Biol. 2010, 88, 813-822
185. Dostert, C.; Pétrilli, V.; Van Bruggen, R.; Steele, C.; Mossman, B. T.; Tschopp, J. Innate Immune Activation through Nalp3 Inflammasome Sensing of Asbestos and Silica Science 2008, 320, 674-677
186. Nehaus, V.; Chichester, J. A.; Ebensen, T.; Schwarz, K.; Hartman, C. E.; Shoji, Y.; Guzmán, C. A.; Yusibov, V.; Sewald, K.; Braun, A. A New Adjuvanted Nanoparticle-Based H1N1 Influenza Vaccine Induced Antigen-Specific Local Mucosal and Systemic Immune Responses after Administration into the Lung Vaccine 2014, 32, 3216-3222
187. Ulery, B. D.; Kumar, D.; Ramer-Tait, A. E.; Metzger, D. W.; Wannemuehler, M. J.; Narasimhan, B. Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases PLoS One 2011, 6, 1-8
188. Jones, M.-C.; Jones, S. a; Riffo-Vasquez, Y.; Spina, D.; Hoffman, E.; Morgan, A.; Patel, A.; Page, C.; Forbes, B.; Dailey, L. A. Quantitative Assessment of Nanoparticle Surface Hydrophobicity and Its Influence on Pulmonary Biocompatibility J. Controlled Release 2014, 183, 94-104
189. Huynh, N. T.; Passirani, C.; Saulnier, P.; Benoit, J. P. Lipid Nanocapsules: A New Platform for Nanomedicine Int. J. Pharm. 2009, 379, 201-209
190. Tobio, M.; Gref, R.; Sanchez, A.; Langer, R.; Alonso, M. Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration Pharm. Res. 1998, 15, 270-275
191. Plapied, L.; Duhem, N.; des Rieux, A.; Préat, V. Fate of Polymeric Nanocarriers for Oral Drug Delivery Curr. Opin. Colloid Interface Sci. 2011, 16, 228-237
192. Desai, M. P.; Labhasetwar, V.; Amidon, G. L.; Levy, R. J. Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size Pharm. Res. 1996, 13, 1838-1845
193. Wang, T.; Zou, M.; Jiang, H.; Ji, Z.; Gao, P.; Cheng, G. Synthesis of a Novel Kind of Carbon Nanoparticle with Large Mesopores and Macropores and Its Application as an Oral Vaccine Adjuvant Eur. J. Pharm. Sci. 2011, 44, 653-659
194. Barhate, G.; Gautam, M.; Gairola, S.; Jadhav, S.; Pokharkar, V. Quillaja Saponaria Extract as Mucosal Adjuvant with Chitosan Functionalized Gold Nanoparticles for Mucosal Vaccine Delivery: Stability and Immunoefficiency Studies Int. J. Pharm. 2013, 441, 636-642
195. Barhate, G.; Gautam, M.; Gairola, S.; Jadhav, S.; Pokharkar, V. Enhanced Mucosal Immune Responses against Tetanus Toxoid Using Novel Delivery System Comprised of Chitosan-Functionalized Gold Nanoparticles and Botanical Adjuvant: Characterization, Immunogenicity, and Stability Assessment J. Pharm. Sci. 2014, 103, 3448-3456
196. Mabbott, N. A.; Donaldson, D. S.; Ohno, H.; Williams, I. R.; Mahajan, A. Microfold (M) Cells: Important Immunosurveillance Posts in the Intestinal Epithelium Mucosal Immunol. 2013, 6, 666-677
197. Gupta, P. N.; Vyas, S. P. Investigation of Lectinized Liposomes as M-Cell Targeted Carrier-Adjuvant for Mucosal Immunization Colloids Surf. B: Biointerfaces 2011, 82, 118-125
198. Gupta, P. N.; Khatri, K.; Goyal, A. K.; Mishra, N.; Vyas, S. P. M-Cell Targeted Biodegradable PLGA Nanoparticles for Oral Immunization against Hepatitis B J. Drug Targeting 2007, 15, 701-713
199. Fievez, V.; Plapied, L.; des Rieux, A.; Pourcelle, V.; Freichels, H.; Wascotte, V.; Vanderhaeghen, M.-L.; Jerôme, C.; Vanderplasschen, A.; Marchand-Brynaert, J. et al. Targeting Nanoparticles to M Cells with Non-Peptidic Ligands for Oral Vaccination Eur. J. Pharm. Biopharm. 2009, 73, 16-24
200. Slütter, B.; Plapied, L.; Fievez, V.; Sande, M. A.; des Rieux, A.; Schneider, Y.-J.; Van Riet, E.; Jiskoot, W.; Préat, V. Mechanistic Study of the Adjuvant Effect of Biodegradable Nanoparticles in Mucosal Vaccination J. Controlled Release 2009, 138, 113-121
201. Hejazi, R.; Amiji, M. Chitosan-Based Gastrointestinal Delivery Systems J. Controlled Release 2003, 89, 151-165
202. Jain, S.; Sharma, R. K.; Vyas, S. P. Chitosan Nanoparticles Encapsulated Vesicular Systems for Oral Immunization: Preparation, in-Vitro and in-Vivo Characterization J. Pharm. Pharmacol. 2006, 58, 303-310
203. Harde, H.; Agrawal, A. K.; Jain, S. Development of Stabilized Glucomannosylated Chitosan Nanoparticles Using Tandem Crosslinking Method for Oral Vaccine Delivery Nanomedicine (London) 2014, 9, 2511-2529
204. Dudeja, P. K.; Tyagi, S.; Gill, R.; Said, H. M. Evidence for a Carrier-Mediated Mechanism for Thiamine Transport to Human Jejunal Basolateral Membrane Vesicles Dig. Dis. Sci. 2003, 48, 109-115
205. Salman, H. H.; Gamazo, C.; Agüeros, M.; Irache, J. M. Bioadhesive Capacity and Immunoadjuvant Properties of Thiamine-Coated Nanoparticles Vaccine 2007, 25, 8123-8132
206. Cario, E.; Gerken, G.; Podolsky, D. K. Toll-like Receptor 2 Enhances ZO-1-Associated Intestinal Epithelial Barrier Integrity via Protein Kinase C Gastroenterology 2004, 127, 224-238
207. Chabot, S.; Wagner, J. S.; Farrant, S.; Neutra, M. R. TLRs Regulate the Gatekeeping Functions of the Intestinal Follicle-Associated Epithelium J. Immunol. 2006, 176, 4275-4283
208. Chabot, S. M.; Chernin, T. S.; Shawi, M.; Wagner, J.; Farrant, S.; Burt, D. S.; Cyr, S.; Neutra, M. R. TLR2 Activation by Proteosomes Promotes Uptake of Particulate Vaccines at Mucosal Surfaces Vaccine 2007, 25, 5348-5358
209. Yuan, H.; Chen, C.-Y.; Chai, G.-H.; Du, Y.-Z.; Hu, F.-Q. Improved Transport and Absorption through Gastrointestinal Tract by PEGylated Solid Lipid Nanoparticles Mol. Pharmaceutics 2013, 10, 1865-1873
210. Zhu, Q.; Talton, J.; Zhang, G.; Cunningham, T.; Wang, Z.; Waters, R. C.; Kirk, J.; Eppler, B.; Klinman, D. M.; Sui, Y. et al. Large Intestine-Targeted, Nanoparticle-Releasing Oral Vaccine to Control Genitorectal Viral Infection Nat. Med. 2012, 18, 1291-1296
211. In Immunity Against Mucosal Pathogens; Vajdy, M., Ed.; Springer: Dordrecht, Netherlands, 2008.
212. Ochiel, D. O.; Fahey, J. V.; Ghosh, M.; Haddad, S. N.; Wira, C. R. Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens Curr. Womens Health Rev. 2008, 4, 102-117
213. Soboll, G.; Schaefer, T. M.; Wira, C. R. Effect of Toll-like Receptor (TLR) Agonists on TLR and Microbicide Expression in Uterine and Vaginal Tissues of the Mouse Am. J. Reprod. Immunol. 2006, 55, 434-446
214. Wira, C. R.; Grant-Tschudy, K. S.; Crane-Godreau, M. A. Epithelial Cells in the Female Reproductive Tract: A Central Role as Sentinels of Immune Protection Am. J. Reprod. Immunol. 2005, 53, 65-76
215. Yeaman, G. R.; White, H. D.; Howell, A.; Prabhala, R.; Wira, C. R. The Mucosal Immune System in the Human Female Reproductive Tract: Potential Insights into the Heterosexual Transmission of HIV AIDS Res. Hum. Retroviruses 1998, 14 (Suppl 1) S57-S62
216. Lai, S. K.; OHanlon, D. E.; Harrold, S.; Man, S. T.; Wang, Y.-Y.; Cone, R.; Hanes, J. Rapid Transport of Large Polymeric Nanoparticles in Fresh Undiluted Human Mucus Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 1482-1487
217. Bures, P.; Huang, Y.; Oral, E.; Peppas, N. A. Surface Modifications and Molecular Imprinting of Polymers in Medical and Pharmaceutical Applications J. Controlled Release 2001, 72, 25-33
218. Wang, Y.-Y.; Lai, S. K.; Suk, J. S.; Pace, A.; Cone, R.; Hanes, J. Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles That "Slip" through the Human Mucus Barrier Angew. Chem., Int. Ed. Engl. 2008, 47, 9726-9729
219. Ensign, L. M.; Tang, B. C.; Wang, Y.-Y.; Tse, T. A.; Hoen, T.; Cone, R.; Hanes, J. Mucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus Sci. Transl. Med. 2012, 4, 138ra79
220. Ensign, L. M.; Hoen, T. E.; Maisel, K.; Cone, R. A.; Hanes, J. S. Enhanced Vaginal Drug Delivery through the Use of Hypotonic Formulations That Induce Fluid Uptake Biomaterials 2013, 34, 6922-6929
221. Kuo-Haller, P.; Cu, Y.; Blum, J.; Appleton, J. A.; Saltzman, W. M. Vaccine Delivery by Polymeric Vehicles in the Mouse Reproductive Tract Induces Sustained Local and Systemic Immunity Mol. Pharmaceutics 2010, 7, 1585-1595
222. Glenn, G. M.; Kenney, R. T.; Ellingsworth, L. R.; Frech, S. A.; Hammond, S. A.; Zoeteweij, J. P. Transcutaneous Immunization and Immunostimulant Strategies: Capitalizing on the Immunocompetence of the Skin Expert Rev. Vaccines 2003, 2, 253-267
223. Rancan, F.; Gao, Q.; Graf, C.; Troppens, S.; Hadam, S.; Hackbarth, S.; Kembuan, C.; Blume-Peytavi, U.; Rühl, E.; Lademann, J. et al. Skin Penetration and Cellular Uptake of Amorphous Silica Nanoparticles with Variable Size, Surface Functionalization, and Colloidal Stability ACS Nano 2012, 6, 6829-6842
224. Mishra, D.; Dubey, V.; Asthana, A.; Saraf, D. K.; Jain, N. K. Elastic Liposomes Mediated Transcutaneous Immunization against Hepatitis B Vaccine 2006, 24, 4847-4855
225. Li, N.; Peng, L.-H.; Chen, X.; Zhang, T.-Y.; Shao, G.-F.; Liang, W.-Q.; Gao, J.-Q. Antigen-Loaded Nanocarriers Enhance the Migration of Stimulated Langerhans Cells to Draining Lymph Nodes and Induce Effective Transcutaneous Immunization Nanomedicine 2014, 10, 215-223
226. Mittal, A.; Schulze, K.; Ebensen, T.; Weißmann, S.; Hansen, S.; Lehr, C. M.; Guzman, C. A. Efficient Nanoparticle-Mediated Needle-Free Transcutaneous Vaccination via Hair Follicles Requires Adjuvantation Nanomedicine 2014, 11, 147-154
227. Kitaoka, M.; Imamura, K.; Hirakawa, Y.; Tahara, Y.; Kamiya, N.; Goto, M. Needle-Free Immunization Using a Solid-in-Oil Nanodispersion Enhanced by a Skin-Permeable Oligoarginine Peptide Int. J. Pharm. 2013, 458, 334-339
228. Banchereau, J.; Steinman, R. M. Dendritic Cells and the Control of Immunity Nature 1998, 392, 245-252
229. Harding, C. V.; Collins, D. S.; Slot, J. W.; Geuze, H. J.; Unanue, E. R. Liposome-Encapsulated Antigens Are Processed in Lysosomes, Recycled, and Presented to T Cells Cell 1991, 64, 393-401
230. Bachmann, M. F.; Jennings, G. T. Vaccine Delivery: A Matter of Size, Geometry, Kinetics and Molecular Patterns Nat. Rev. Immunol. 2010, 10, 787-796
231. Foged, C.; Arigita, C.; Sundblad, A.; Jiskoot, W.; Storm, G.; Frokjaer, S. Interaction of Dendritic Cells with Antigen-Containing Liposomes: Effect of Bilayer Composition Vaccine 2004, 22, 1903-1913
232. Villa, C. H.; Dao, T.; Ahearn, I.; Fehrenbacher, N.; Casey, E.; Rey, D. A.; Korontsvit, T.; Zakhaleva, V.; Batt, C. A.; Philips, M. R. et al. Single-Walled Carbon Nanotubes Deliver Peptide Antigen into Dendritic Cells and Enhance IgG Responses to Tumor-Associated Antigens ACS Nano 2011, 5, 5300-5311
233. Xu, Q.-H.; Zhao, X.-N.; Cheng, J.-P.; Wei, C.-H.; Zhang, Q.-H.; Rong, K.-T. Influence of Carrier Proteins on the Immunologic Response to Haptenic Antitetrodotoxin Vaccine Bioconjugate Chem. 2006, 17, 1508-1513
234. Helling, F.; Shang, A.; Calves, M.; Zhang, S.; Ren, S.; Yu, R. K.; Oettgen, H. F.; Livingston, P. O. GD3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines Cancer Res. 1994, 54, 197-203
235. Ingale, S.; Wolfert, M. A.; Gaekwad, J.; Buskas, T.; Boons, G.-J. Robust Immune Responses Elicited by a Fully Synthetic Three-Component Vaccine Nat. Chem. Biol. 2007, 3, 663-667
236. Black, M.; Trent, A.; Tirrell, M.; Olive, C. Advances in the Design and Delivery of Peptide Subunit Vaccines with a Focus on Toll-like Receptor Agonists Expert Rev. Vaccines 2010, 9, 157-173
237. Joffre, O. P.; Segura, E.; Savina, A.; Amigorena, S. Cross-Presentation by Dendritic Cells Nat. Rev. Immunol. 2012, 12, 557-569
238. Brode, S.; MacAry, P. A. Cross-Presentation: Dendritic Cells and Macrophages Bite off More than They Can Chew! Immunology 2004, 112, 345-351
239. Amigorena, S.; Savina, A. Intracellular Mechanisms of Antigen Cross Presentation in Dendritic Cells Curr. Opin. Immunol. 2010, 22, 109-117
240. Kovacsovics-Bankowski, M.; Clark, K.; Benacerraf, B.; Rock, K. L. Efficient Major Histocompatibility Complex Class I Presentation of Exogenous Antigen upon Phagocytosis by Macrophages Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4942-4946
241. Kovacsovics-Bankowski, M.; Rock, K. L. A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules Science 1995, 267, 243-246
242. Reis e Sousa, C.; Germain, R. N. Major Histocompatibility Complex Class I Presentation of Peptides Derived from Soluble Exogenous Antigen by a Subset of Cells Engaged in Phagocytosis J. Exp. Med. 1995, 182, 841-851
243. Harding, C. V.; Song, R. Phagocytic Processing of Exogenous Particulate Antigens by Macrophages for Presentation by Class I MHC Molecules J. Immunol. 1994, 153, 4925-4933
244. Jain, S.; Yap, W. T.; Irvine, D. J. Synthesis of Protein-Loaded Hydrogel Particles in an Aqueous Two-Phase System for Coincident Antigen and CpG Oligonucleotide Delivery to Antigen-Presenting Cells Biomacromolecules 2005, 6, 2590-2600
245. Hamdy, S.; Elamanchili, P.; Alshamsan, A.; Molavi, O.; Satou, T.; Samuel, J. Enhanced Antigen-Specific Primary CD4+ and CD8+ Responses by Codelivery of Ovalbumin and Toll-like Receptor Ligand Monophosphoryl Lipid A in poly(D,L-Lactic-Co-Glycolic Acid) Nanoparticles J. Biomed. Mater. Res., Part A 2007, 81A, 652-662
246. Taneichi, M.; Ishida, H.; Kajino, K.; Tanaka, Y.; Kasai, M.; Nishida, M.; Yamamura, H.; Uchida, T.; Alerts, E. Antigen Chemically Coupled to the Surface of Liposomes Are Cross-Presented to CD8 + T Cells and Induce Potent Antitumor Immunity J. Immunol. 2006, 177, 2324-2330
247. Tanaka, Y.; Taneichi, M.; Kasai, M.; Kakiuchi, T.; Uchida, T. Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8 T Cells PLoS One 2010, 5, e15225
248. Arias, M. a; Loxley, A.; Eatmon, C.; Van Roey, G.; Fairhurst, D.; Mitchnick, M.; Dash, P.; Cole, T.; Wegmann, F.; Sattentau, Q. et al. Carnauba Wax Nanoparticles Enhance Strong Systemic and Mucosal Cellular and Humoral Immune Responses to HIV-gp140 Antigen Vaccine 2011, 29, 1258-1269
249. Lee, I. H.; Kwon, H. K.; An, S.; Kim, D.; Kim, S.; Yu, M. K.; Lee, J. H.; Lee, T. S.; Im, S. H.; Jon, S. Imageable Antigen-Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy in Vivo Angew. Chem., Int. Ed. 2012, 51, 8800-8805
250. Ahn, S.; Lee, I. H.; Kang, S.; Kim, D.; Choi, M.; Saw, P. E.; Shin, E. C.; Jon, S. Gold Nanoparticles Displaying Tumor-Associated Self-Antigens as a Potential Vaccine for Cancer Immunotherapy Adv. Healthcare Mater. 2014, 3, 1194-1199
251. Moon, J. J.; Suh, H.; Bershteyn, A.; Stephan, M. T.; Liu, H.; Huang, B.; Sohail, M.; Luo, S.; Ho Um, S.; Khant, H. et al. Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses Nat. Mater. 2011, 10, 243-251
252. Nordly, P.; Rose, F.; Christensen, D.; Nielsen, H. M.; Andersen, P.; Agger, E. M.; Foged, C. Immunity by Formulation Design: Induction of High CD8+ T-Cell Responses by poly(I:C) Incorporated into the CAF01 Adjuvant via a Double Emulsion Method J. Controlled Release 2011, 150, 307-317
253. Li, A. V.; Eby, J. K.; DeMuth, P. C.; Irvine, D. J. Novel Synthetic Vesicle for Rapid in Vivo Expansion of CD8 T Cells Can Significantly Improve Checkpoint Inhibitor Therapy. American Association for Cancer Research Annual Meeting; American Association for Cancer Research (AACR), Philadelphia, PA, 2015.
254. Van der Vlies, A. J.; ONeil, C. P.; Hasegawa, U.; Hammond, N.; Hubbell, J. A. Synthesis of Pyridyl Disulfide-Functionalized Nanoparticles for Conjugating Thiol -Containing Small Molecules, Peptides and Proteins.pdf Bioconjugate Chem. 2010, 21, 653-662
255. Hirosue, S.; Kourtis, I. C.; van der Vlies, A. J.; Hubbell, J. A.; Swartz, M. A. Antigen Delivery to Dendritic Cells by Poly(propylene Sulfide) Nanoparticles with Disulfide Conjugated Peptides: Cross-Presentation and T Cell Activation Vaccine 2010, 28, 7897-7906
256. Stano, A.; Scott, E. A.; Dane, K. Y.; Swartz, M. A.; Hubbell, J. A. Tunable T Cell Immunity towards a Protein Antigen Using Polymersomes vs. Solid-Core Nanoparticles Biomaterials 2013, 34, 4339-4346
257. Wilson, J. T.; Keller, S.; Manganiello, M. J.; Cheng, C.; Lee, C.; Opara, C.; Convertine, A.; Stayton, P. S. pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides ACS Nano 2013, 7, 3912-3925
258. Keller, S.; Wilson, J. T.; Patilea, G. I.; Kern, H. B.; Convertine, A. J.; Stayton, P. S. Neutral Polymer Micelle Carriers with pH-Responsive, Endosome-Releasing Activity Modulate Antigen Trafficking to Enhance CD8+ T Cell Responses J. Controlled Release 2014, 191, 24-33
259. Solbrig, C. M.; Saucier-Sawyer, J. K.; Cody, V.; Saltzman, W. M.; Hanlon, D. J. Polymer Nanoparticles for Immunotherapy from Encapsulated Tumor-Associated Antigens and Whole Tumor Cells Mol. Pharmaceutics 2007, 4, 47-57
260. Fang, R. H.; Hu, C. J.; Luk, B. T.; Gao, W.; Copp, J. A.; Tai, Y.; Connor, D. E. O.; Zhang, L. Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery Nano Lett. 2014, 14, 2181-2188
261. Modery-Pawlowski, C. L.; Gupta, A. Sen. Heteromultivalent Ligand-Decoration for Actively Targeted Nanomedicine Biomaterials 2014, 35, 2568-2579
262. Elamanchili, P.; Lutsiak, C. M. E.; Hamdy, S.; Diwan, M.; Samuel, J. Pathogen-Mimicking Nanoparticles for Vaccine Delivery to Dendritic Cells J. Immunother. 2007, 30, 378-395
263. Hamdy, S.; Molavi, O.; Ma, Z.; Haddadi, A.; Alshamsan, A.; Gobti, Z.; Elhasi, S.; Samuel, J.; Lavasanifar, A. Co-Delivery of Cancer-Associated Antigen and Toll-like Receptor 4 Ligand in PLGA Nanoparticles Induces Potent CD8+ T Cell-Mediated Anti-Tumor Immunity Vaccine 2008, 26, 5046-5057
264. Zhang, Z.; Tongchusak, S.; Mizukami, Y.; Kang, Y. J.; Ioji, T.; Touma, M.; Reinhold, B.; Keskin, D. B.; Reinherz, E. L.; Sasada, T. Induction of Anti-Tumor Cytotoxic T Cell Responses through PLGA-Nanoparticle Mediated Antigen Delivery Biomaterials 2011, 32, 3666-3678
265. Hu, Y.; Litwin, T.; Nagaraja, a R.; Kwong, B.; Katz, J.; Watson, N.; Irvine, D. J. Cytosolic Delivery of Membrane Impermeable Molecules in Dendritic Cells Using pH Responsive Core-Shell Nanoparticles Nano Lett. 2007, 7 (10) 3056-3064
266. Hu, Y.; Atukorale, P. U.; Lu, J. J.; Moon, J. J.; Um, S. H.; Cho, E. L.; Wang, Y.; Chen, J.; Irvine, D. J. Cytosolic Delivery Mediated via Electrostatic Surface Binding of Protein, Virus, or siRNA Cargos to Ph-Responsive Core-Shell Gel Particles Biomacromolecules 2009, 10, 756-765
267. Li, P.; Luo, Z.; Liu, P.; Gao, N.; Zhang, Y.; Pan, H.; Liu, L.; Wang, C.; Cai, L.; Ma, Y. Bioreducible Alginate-Poly(ethylenimine) Nanogels as an Antigen-Delivery System Robustly Enhance Vaccine-Elicited Humoral and Cellular Immune Responses J. Controlled Release 2013, 168, 271-279
268. Xu, L.; Liu, Y.; Chen, Z.; Li, W.; Liu, Y.; Wang, L.; Liu, Y.; Wu, X.; Ji, Y.; Zhao, Y. et al. Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment Nano Lett. 2012, 12, 2003-2012
269. Broaders, K. E.; Cohen, J. a; Beaudette, T. T.; Bachelder, E. M.; Fréchet, J. M. J. Acetalated Dextran Is a Chemically and Biologically Tunable Material for Particulate Immunotherapy Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 5497-5502
270. Mukai, Y.; Yoshinaga, T.; Yoshikawa, M.; Matsuo, K.; Yoshikawa, T.; Matsuo, K.; Niki, K.; Yoshioka, Y.; Okada, N.; Nakagawa, S. Induction of Endoplasmic Reticulum-Endosome Fusion for Antigen Cross-Presentation Induced by Poly (-Glutamic Acid) Nanoparticles J. Immunol. 2011, 187, 6249-6255
271. Sneh-Edri, H. Intracellular Targeting of PLGA Nanoparticles Encapsulating Antigenic Peptide to the Endoplasmic Reticulum of Dendritic Cells and Its Effect on Antigen Cross-presentation in vitro Mol. Pharm. 2011, 8, 1266-1275
272. Yuba, E.; Kojima, C.; Harada, A.; Tana; Watarai, S.; Kono, K. pH-Sensitive Fusogenic Polymer-Modified Liposomes as a Carrier of Antigenic Proteins for Activation of Cellular Immunity Biomaterials 2010, 31, 943-951
273. Yuba, E.; Harada, A.; Sakanishi, Y.; Watarai, S.; Kono, K. A Liposome-Based Antigen Delivery System Using pH-Sensitive Fusogenic Polymers for Cancer Immunotherapy Biomaterials 2013, 34, 3042-3052
274. Waeckerle-Men, Y.; Mauracher, A.; Hakerud, M.; Mohanan, D.; Kündig, T. M.; Høgset, A.; Johansen, P. Photochemical Targeting of Antigens to the Cytosol for Stimulation of MHC Class-I-Restricted T-Cell Responses Eur. J. Pharm. Biopharm. 2013, 85, 34-41
275. Macho Fernandez, E.; Chang, J.; Fontaine, J.; Bialecki, E.; Rodriguez, F.; Werkmeister, E.; Krieger, V.; Ehret, C.; Heurtault, B.; Fournel, S. et al. Activation of Invariant Natural Killer T Lymphocytes in Response to the A-Galactosylceramide Analogue KRN7000 Encapsulated in PLGA-Based Nanoparticles and Microparticles Int. J. Pharm. 2012, 423, 45-54
276. Ishii, M.; Kojima, N. Effective Stimulation of Invariant Natural Killer T Cells by Oligomannose-Coated Liposomes Int. Immunopharmacol. 2013, 15, 685-692
277. Nakamura, T.; Moriguchi, R.; Kogure, K.; Shastri, N.; Harashima, H. Efficient MHC Class I Presentation by Controlled Intracellular Trafficking of Antigens in Octaarginine-Modified Liposomes Mol. Ther. 2008, 16, 1507-1514
278. Nakamura, T.; Yamazaki, D.; Yamauchi, J.; Harashima, H. The Nanoparticulation by Octaarginine-Modified Liposome Improves A-Galactosylceramide-Mediated Antitumor Therapy via Systemic Administration J. Controlled Release 2013, 171, 216-224
279. Shen, H.; Ackerman, A. L.; Cody, V.; Giodini, A.; Hinson, E. R.; Cresswell, P.; Edelson, R. L.; Saltzman, W. M.; Hanlon, D. J. Enhanced and Prolonged Cross-Presentation Following Endosomal Escape of Exogenous Antigens Encapsulated in Biodegradable Nanoparticles Immunology 2006, 117, 78-88
280. Demento, S. L.; Cui, W.; Criscione, J. M.; Stern, E.; Tulipan, J.; Kaech, S. M.; Fahmy, T. M. Role of Sustained Antigen Release from Nanoparticle Vaccines in Shaping the T Cell Memory Phenotype Biomaterials 2012, 33, 4957-4964
281. Saluja, S. S.; Hanlon, D. J.; Sharp, F. A.; Hong, E.; Khalil, D.; Robinson, E.; Tigelaar, R.; Fahmy, T. M.; Edelson, R. L. Targeting Human Dendritic Cells via DEC-205 Using PLGA Nanoparticles Leads to Enhanced Cross-Presentation of a Melanoma-Associated Antigen Int. J. Nanomedicine 2014, 9, 5231-5246
282. Schietinger, A.; Greenberg, P. D. Tolerance and Exhaustion: Defining Mechanisms of T Cell Dysfunction Trends Immunol. 2014, 35, 51-60
283. Crespo, J.; Sun, H.; Welling, T. H.; Tian, Z.; Zou, W. T Cell Anergy, Exhaustion, Senescence, and Stemness in the Tumor Microenvironment Curr. Opin. Immunol. 2013, 25, 214-221
284. Hanlon, D. J.; Aldo, P. B.; Devine, L.; Alvero, A. B.; Engberg, A. K.; Edelson, R.; Mor, G. Enhanced Stimulation of Anti-Ovarian Cancer CD8(+) T Cells by Dendritic Cells Loaded with Nanoparticle Encapsulated Tumor Antigen Am. J. Reprod. Immunol. 2011, 65, 597-609
285. Matzinger, P. The Danger Model: A Renewed Sense of Self Science 2002, 296, 301-305
286. Matzinger, P. Tolerance, Danger, and the Extended Family Annu. Rev. Immunol. 1994, 12, 991-1045
287. Gallucci, S.; Matzinger, P. Danger Signals: SOS to the Immune System Curr. Opin. Immunol. 2001, 13, 114-119
288. Iwasaki, A.; Medzhitov, R. Toll-like Receptor Control of the Adaptive Immune Responses Nat. Immunol. 2004, 5, 987-995
289. Jin, B.; Sun, T.; Yu, X. H.; Yang, Y. X.; Yeo, A. E. T. The Effects of TLR Activation on T-Cell Development and Differentiation Clin. Dev. Immunol. 2012, 2012, 836485
290. Lanzavecchia, A.; Sallusto, F. Toll-like Receptors and Innate Immunity in B-Cell Activation and Antibody Responses Curr. Opin. Immunol. 2007, 19, 268-274
291. Vanlandschoot, P.; Van Houtte, F.; Ulrichts, P.; Tavernier, J.; Leroux-Roels, G. Immunostimulatory Potential of Hepatitis B Nucleocapsid Preparations: Lipopolysaccharide Contamination Should Not Be Overlooked J. Gen. Virol. 2005, 86, 323-331
292. St. John, A. L.; Chan, C. Y.; Staats, H. F.; Leong, K. W.; Abraham, S. N. Synthetic Mast-Cell Granules as Adjuvants to Promote and Polarize Immunity in Lymph Nodes Nat. Mater. 2012, 11, 250-257
293. Hanson, M. C.; Crespo, M. P.; Abraham, W.; Moynihan, K. D.; Szeto, G. L.; Chen, S. H.; Melo, M. B.; Mueller, S.; Irvine, D. J. Nanoparticulate STING Agonists Are Potent Lymph Node-Targeted Vaccine Adjuvants. J. Clin. Invest. 2015.
294. Diwan, M.; Elamanchili, P.; Cao, M.; Samuel, J. Dose Sparing of CpG Oligodeoxynucleotide Vaccine Adjuvants by Nanoparticle Delivery Curr. Drug Delivery 2004, 1, 405-412
295. Tacken, P. J.; Zeelenberg, I. S.; Cruz, L. J.; Van Hout-Kuijer, M. a; Van De Glind, G.; Fokkink, R. G.; Lambeck, A. J. a; Figdor, C. G. Targeted Delivery of Toll-like Receptor Ligands to Human and Mouse Dendritic Cells Strongly Enhances Adjuvanticity Blood 2011, 118, 6836-6844
296. Demento, S. L.; Bonafé, N.; Cui, W.; Kaech, S. M.; Caplan, M. J.; Fikrig, E.; Ledizet, M.; Fahmy, T. M. TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis J. Immunol. 2010, 185, 2989-2997
297. Sokolova, V.; Knuschke, T.; Kovtun, A.; Buer, J.; Epple, M.; Westendorf, A. M. The Use of Calcium Phosphate Nanoparticles Encapsulating Toll-like Receptor Ligands and the Antigen Hemagglutinin to Induce Dendritic Cell Maturation and T Cell Activation Biomaterials 2010, 31, 5627-5633
298. Blander, J. M.; Medzhitov, R. Regulation of Phagosome Maturation by Signals from Science 2004, 304, 1014-1018
299. Blander, J. M.; Medzhitov, R. Toll-Dependent Selection of Microbial Antigens for Presentation by Dendritic Cells Nature 2006, 440, 808-812
300. Hoffmann, E.; Kotsias, F.; Visentin, G.; Bruhns, P.; Savina, A.; Amigorena, S. Autonomous Phagosomal Degradation and Antigen Presentation in Dendritic Cells Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 14556-14561
301. Yates, R. M.; Russell, D. G. Phagosome Maturation Proceeds Independently of Stimulation of Toll-like Receptors 2 and 4 Immunity 2005, 23, 409-717
302. Russell, D. G.; Yates, R. M. TLR Signalling and Phagosome Maturation: An Alternative Viewpoint Cell. Microbiol. 2007, 9, 849-850
303. De Titta, A.; Ballester, M.; Julier, Z.; Nembrini, C.; Jeanbart, L.; van der Vlies, A. J. Nanoparticle Conjugation of CpG Enhances Adjuvancy for Cellular Immunity and Memory Recall at Low Dose Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 19902-19907
304. Mandraju, R.; Murray, S.; Forman, J.; Pasare, C. Differential Ability of Surface and Endosomal TLRs to Induce CD8 T Cell Responses in Vivo J. Immunol. 2014, 192, 4303-4315
305. Dijkstra, J. A. N.; Mellors, J. W.; Ryan, J. L.; Szoka, F. C. Modulation of the Biological Activity of Bacterial Endotoxin by Incorporation into Liposomes J. Immunol. 1987, 138, 2663-2670
306. Napolitani, G.; Rinaldi, A.; Bertoni, F.; Sallusto, F.; Lanzavecchia, A. Selected Toll-like Receptor Agonist Combinations Synergistically Trigger a T Helper Type 1-Polarizing Program in Dendritic Cells Nat. Immunol. 2005, 6, 769-776
307. Bagchi, A.; Herrup, E. a; Warren, H. S.; Trigilio, J.; Shin, H.-S.; Valentine, C.; Hellman, J. MyD88-Dependent and MyD88-Independent Pathways in Synergy, Priming, and Tolerance between TLR Agonists J. Immunol. 2007, 178, 1164-1171
308. Zhu, Q.; Egelston, C.; Vivekanandhan, A.; Uematsu, S.; Akira, S.; Klinman, D. M.; Belyakov, I. M.; Berzofsky, J. a. Toll-like Receptor Ligands Synergize through Distinct Dendritic Cell Pathways to Induce T Cell Responses: Implications for Vaccines Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 16260-16265
309. Kasturi, S. P.; Skountzou, I.; Albrecht, R. A.; Koutsonanos, D.; Hua, T.; Nakaya, H. I.; Ravindran, R.; Stewart, S.; Alam, M.; Kwissa, M. et al. Programming the Magnitude and Persistence of Antibody Responses with Innate Immunity Nature 2011, 470, 543-547
310. Turley, D. M.; Miller, S. D. Peripheral Tolerance Induction Using Ethylenecarbodiimide-Fixed APCs Uses Both Direct and Indirect Mechanisms of Antigen Presentation for Prevention of Experimental Autoimmune Encephalomyelitis J. Immunol. 2007, 178, 2212-2220
311. Getts, D. R.; Turley, D. M.; Smith, C. E.; Harp, C. T.; McCarthy, D.; Feeney, E. M.; Getts, M. T.; Martin, A. J.; Luo, X.; Terry, R. L. et al. Tolerance Induced by Apoptotic Antigen-Coupled Leukocytes Is Induced by PD-L1+ and IL-10-Producing Splenic Macrophages and Maintained by T Regulatory Cells J. Immunol. 2011, 187, 2405-2417
312. Gharagozloo, M.; Majewski, S.; Foldvari, M. Therapeutic Applications of Nanomedicine in Autoimmune Diseases: From Immunosuppression to Tolerance Induction Nanomed. Nanotechnol., Biol. Med. 2015, 11 (4) 1003-1018
313. Hunter, Z.; McCarthy, D. P.; Yap, W. T.; Harp, C. T.; Getts, D. R.; Shea, L. D.; Miller, S. D. A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease ACS Nano 2014, 8, 2148-2160
314. Maldonado, R. a.; LaMothe, R. a.; Ferrari, J. D.; Zhang, A.-H.; Rossi, R. J.; Kolte, P. N.; Griset, A. P.; ONeil, C.; Altreuter, D. H.; Browning, E. et al. Polymeric Synthetic Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance Proc. Natl. Acad. Sci. U.S.A. 2015, 112, E156-E165
315. Selecta Biosciences. Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers https://clinicaltrials.gov/ct2/show/NCT01478893 (accessed May 13, 2015).
316. Look, M.; Stern, E.; Wang, Q. a.; DiPlacido, L. D.; Kashgarian, M.; Craft, J.; Fahmy, T. M. Nanogel-Based Delivery of Mycophenolic Acid Ameliorates Systemic Lupus Erythematosus in Mice J. Clin. Invest. 2013, 123, 1741-1749
317. Look, M.; Saltzman, W. M.; Craft, J.; Fahmy, T. M. The Nanomaterial-Dependent Modulation of Dendritic Cells and Its Potential Influence on Therapeutic Immunosuppression in Lupus Biomaterials 2014, 35, 1089-1095
318. Yeste, a.; Nadeau, M.; Burns, E. J.; Weiner, H. L.; Quintana, F. J. Nanoparticle-Mediated Codelivery of Myelin Antigen and a Tolerogenic Small Molecule Suppresses Experimental Autoimmune Encephalomyelitis Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 11270-11275
319. Tsai, S.; Shameli, A.; Yamanouchi, J.; Clemente-Casares, X.; Wang, J.; Serra, P.; Yang, Y.; Medarova, Z.; Moore, A.; Santamaria, P. Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells Immunity 2010, 32, 568-580
320. Sarma, J. V.; Ward, P. A. The Complement System Cell Tissue Res. 2011, 343, 227-235
321. Bertholon, I.; Vauthier, C.; Labarre, D. Complement Activation by Core-Shell Poly(isobutylcyanoacrylate)-Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide Pharm. Res. 2006, 23, 1313-1323
322. Thomas, S. N.; van der Vlies, A. J.; ONeil, C. P.; Reddy, S. T.; Yu, S. S.; Giorgio, T. D.; Swartz, M. A.; Hubbell, J. A. Engineering Complement Activation on Polypropylene Sulfide Vaccine Nanoparticles Biomaterials 2011, 32, 2194-2203
323. Hamad, I.; Al-Hanbali, O.; Hunter, A. C.; Rutt, K. J.; Andresen, T. L.; Moghimi, S. M. Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere-Serum Interface: Implications for Stealth Nanoparticle Engineering ACS Nano 2010, 4, 6629-6638
324. Deretic, V.; Saitoh, T.; Akira, S. Autophagy in Infection, Inflammation and Immunity Nat. Rev. Immunol. 2013, 13, 722-737
325. Ravindran, R.; Khan, N.; Nakaya, H. I.; Li, S.; Loebbermann, J.; Maddur, M. S.; Park, Y.; Jones, D. P.; Chappert, P.; Davoust, J. et al. Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation Science 2014, 343, 313-318
326. Panzarini, E.; Dini, L. Nanomaterial-Induced Autophagy: A New Reversal MDR Tool in Cancer Therapy? Mol. Pharmaceutics 2014, 11, 2527-2538
327. Li, H.; Li, Y.; Jiao, J.; Hu, H.-M. Alpha-Alumina Nanoparticles Induce Efficient Autophagy-Dependent Cross-Presentation and Potent Antitumour Response Nat. Nanotechnol. 2011, 6, 645-650
328. Zoete, M. R. De; Palm, N. W.; Zhu, S.; Flavell, R. A. Inflammasomes Cold Spring Harbor Perspect. Biol. 2014, 6, a016287
329. Hornung, V.; Bauernfeind, F.; Halle, A.; Samstad, E. O.; Kono, H.; Rock, K. L.; Fitzgerald, K. A.; Latz, E. Silica Crystals and Aluminum Salts Activate the NALP3 Inflammasome through Phagosomal Destabilization Nat. Immunol. 2008, 9, 847-856
330. Eisenbarth, S. C.; Colegio, O. R.; OConnor, W.; Sutterwala, F. S.; Flavell, R. a. Crucial Role for the Nalp3 Inflammasome in the Immunostimulatory Properties of Aluminium Adjuvants Nature 2008, 453, 1122-1126
331. Kool, M.; Pétrilli, V.; De Smedt, T.; Rolaz, A.; Hammad, H.; van Nimwegen, M.; Bergen, I. M.; Castillo, R.; Lambrecht, B. N.; Tschopp, J. Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome J. Immunol. 2008, 181, 3755-3759
332. Franchi, L.; Núñez, G. The Nlrp3 Inflammasome Is Critical for Aluminium Hydroxide-Mediated IL-1beta Secretion but Dispensable for Adjuvant Activity Eur. J. Immunol. 2008, 38, 2085-2089
333. McKee, A. S.; Munks, M. W.; MacLeod, M. K. L.; Fleenor, C. J.; Van Rooijen, N.; Kappler, J. W.; Marrack, P. Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, but These Sensors Are Not Required for Alum to Act as an Adjuvant for Specific Immunity J. Immunol. 2009, 183, 4403-4414
334. Harris, J.; Sharp, F. A.; Lavelle, E. C. The Role of Inflammasomes in the Immunostimulatory Effects of Particulate Vaccine Adjuvants Eur. J. Immunol. 2010, 40, 634-638
335. Demento, S. L.; Eisenbarth, S. C.; Foellmer, H. G.; Platt, C.; Caplan, M. J.; Mark Saltzman, W.; Mellman, I.; Ledizet, M.; Fikrig, E.; Flavell, R. a. et al. Inflammasome-Activating Nanoparticles as Modular Systems for Optimizing Vaccine Efficacy Vaccine 2009, 27, 3013-3021
336. Sharp, F. a; Ruane, D.; Claass, B.; Creagh, E.; Harris, J.; Malyala, P.; Singh, M.; OHagan, D. T.; Pétrilli, V.; Tschopp, J. et al. Uptake of Particulate Vaccine Adjuvants by Dendritic Cells Activates the NALP3 Inflammasome Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 870-875
337. Niikura, K.; Matsunaga, T.; Suzuki, T.; Kobayashi, S.; Yamaguchi, H.; Orba, Y.; Kawaguchi, A.; Hasegawa, H.; Kajino, K.; Ninomiya, T. et al. Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo ACS Nano 2013, 7, 3926-3938
338. Williams, G. R.; Fierens, K.; Preston, S. G.; Lunn, D.; Rysnik, O.; De Prijck, S.; Kool, M.; Buckley, H. C.; Lambrecht, B. N.; OHare, D. et al. Immunity Induced by a Broad Class of Inorganic Crystalline Materials Is Directly Controlled by Their Chemistry J. Exp. Med. 2014, 211, 1019-1025
339. Sun, B.; Ji, Z.; Liao, Y. P.; Wang, M.; Wang, X.; Dong, J.; Chang, C. H.; Li, R.; Zhang, H.; Nel, A. E. et al. Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles ACS Nano 2013, 7, 10834-10849
340. Seong, S.-Y.; Matzinger, P. Hydrophobicity: An Ancient Damage-Associated Molecular Pattern That Initiates Innate Immune Responses Nat. Rev. Immunol. 2004, 4, 469-478
341. Shima, F.; Akagi, T.; Uto, T.; Akashi, M. Manipulating the Antigen-Specific Immune Response by the Hydrophobicity of Amphiphilic Poly(γ-Glutamic Acid) Nanoparticles Biomaterials 2013, 34, 9709-9716
342. Moyano, D. F.; Goldsmith, M.; Solfiell, D. J.; Landesman-Milo, D.; Miranda, O. R.; Peer, D.; Rotello, V. M. Nanoparticle Hydrophobicity Dictates Immune Response J. Am. Chem. Soc. 2012, 134, 3965-3967
343. Petersen, L. K.; Ramer-Tait, A. E.; Broderick, S. R.; Kong, C. S.; Ulery, B. D.; Rajan, K.; Wannemuehler, M. J.; Narasimhan, B. Activation of Innate Immune Responses in a Pathogen-Mimicking Manner by Amphiphilic Polyanhydride Nanoparticle Adjuvants Biomaterials 2011, 32, 6815-6822
344. Chou, L. Y. T.; Zagorovsky, K.; Chan, W. C. W. DNA Assembly of Nanoparticle Superstructures for Controlled Biological Delivery and Elimination Nat. Nanotechnol. 2014, 9, 148-155
345. Gungor, B.; Yagci, F. C.; Tincer, G.; Bayyurt, B.; Alpdundar, E.; Yildiz, S.; Ozcan, M.; Gursel, I.; Gursel, M. CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity Sci. Transl. Med. 2014, 6, 235ra61
346. Mohri, K.; Takahashi, N.; Nishikawa, M.; Kusuki, E.; Shiomi, T.; Takahashi, Y.; Takakura, Y. Increased Immunostimulatory Activity of Polypod-like Structured DNA by Ligation of the Terminal Loop Structures J. Controlled Release 2012, 163, 285-292
347. Van Lehn, R. C.; Ricci, M.; Silva, P. H. J.; Andreozzi, P.; Reguera, J.; Voïtchovsky, K.; Stellacci, F.; Alexander-Katz, A. Lipid Tail Protrusions Mediate the Insertion of Nanoparticles into Model Cell Membranes Nat. Commun. 2014, 5, 4482
348. Bonnaud, C.; Monnier, C. A.; Demurtas, D.; Jud, C.; Vanhecke, D.; Montet, X.; Hovius, R.; Lattuada, M.; Rothen-Rutishauser, B.; Petri-Fink, A. Insertion of Nanoparticle Clusters into Vesicle Bilayers ACS Nano 2014, 8, 3451-3460
349. Zhang, S.; Sun, H.-J.; Hughes, A. D.; Moussodia, R.-O.; Bertin, A.; Chen, Y.; Pochan, D. J.; Heiney, P. A.; Klein, M. L.; Percec, V. Self-Assembly of Amphiphilic Janus Dendrimers into Uniform Onion-like Dendrimersomes with Predictable Size and Number of Bilayers Proc. Natl. Acad. Sci. U.S.A. 2014, 111, 9058-9063
350. Tang, R.; Kim, C. S.; Solfiell, D. J.; Rana, S.; Mout, R.; Velázquez-Delgado, E. M.; Chompoosor, A.; Jeong, Y.; Yan, B.; Zhu, Z.-J. et al. Direct Delivery of Functional Proteins and Enzymes to the Cytosol Using Nanoparticle-Stabilized Nanocapsules ACS Nano 2013, 7, 6667-6673
351. Xia, Y.; Nguyen, T. D.; Yang, M.; Lee, B.; Santos, A.; Podsiadlo, P.; Tang, Z.; Glotzer, S. C.; Kotov, N. A. Self-Assembly of Self-Limiting Monodisperse Supraparticles from Polydisperse Nanoparticles Nat. Nanotechnol. 2011, 6, 580-587
352. Ataman-Onal, Y.; Munier, S.; Ganée, A.; Terrat, C.; Durand, P.-Y.; Battail, N.; Martinon, F.; Le Grand, R.; Charles, M.-H.; Delair, T. et al. Surfactant-Free Anionic PLA Nanoparticles Coated with HIV-1 p24 Protein Induced Enhanced Cellular and Humoral Immune Responses in Various Animal Models J. Controlled Release 2006, 112, 175-185
353. Himeno, A.; Akagi, T.; Uto, T.; Wang, X.; Baba, M.; Ibuki, K.; Matsuyama, M.; Horiike, M.; Igarashi, T.; Miura, T. et al. Evaluation of the Immune Response and Protective Effects of Rhesus Macaques Vaccinated with Biodegradable Nanoparticles Carrying gp120 of Human Immunodeficiency Virus Vaccine 2010, 28, 5377-5385
354. Scheerlinck, J.-P. Y.; Gloster, S.; Gamvrellis, A.; Mottram, P. L.; Plebanski, M. Systemic Immune Responses in Sheep, Induced by a Novel Nano-Bead Adjuvant Vaccine 2006, 24, 1124-1131
355. Tsuji, K.; Hamada, T.; Uenaka, A.; Wada, H.; Sato, E.; Isobe, M.; Asagoe, K.; Yamasaki, O.; Shiku, H.; Ritter, G. et al. Induction of Immune Response against NY-ESO-1 by CHP-NY-ESO-1 Vaccination and Immune Regulation in a Melanoma Patient Cancer Immunol. Immunother. 2008, 57, 1429-1437
356. Fraser, C. C.; Altreuter, D. H.; Ilyinskii, P.; Pittet, L.; LaMothe, R. A.; Keegan, M.; Johnston, L.; Kishimoto, T. K. Generation of a Universal CD4Memory T Cell Recall Peptide Effective in Humans, Mice and Non-Human Primates Vaccine 2014, 32, 2896-2903